Matthias Bartneck, PhD
Department of Medicine III, University Hospital Aachen, 52074 Aachen, Germany
Matthias Bartneck graduated from the University of Bielefeld with a diploma in biology in 2007 where he performed metabolite and gene expression profiling of human primary breast cancer at the chair of genetics. Immune cell signatures, specifically of macrophages, in cancer samples raised his interest in immunology. He pursued his research at RWTH Aachen University where he studied effects of nanomaterials on human primary immune cells and obtained a doctor of natural sciences in 2010. His current research at medical clinic III at the University Hospital Aachen covers targeted immunomodulatory nanomedicine facilitating lipid, micellar, polymer and metal-based nanocarriers and combined molecular imaging and cell sorting. He is a member of the European network Mye-EUNITER which is devoted to trigger exploratory research on myeloid regulatory cells.